aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Bionaut Labs, founded with a mission to revolutionize the treatment of central nervous system (CNS) disorders, leverages precision medicine through remote-controlled micro-robots known as Bionauts. These micro-robots are designed to navigate complex 3D trajectories within the human body, providing local treatment and diagnostic detection in deep anatomical locations. The company's vision is to offer safer and more effective treatments for CNS disorders by achieving accurate and direct access to intricate brain structures.
Notable figures associated with Bionaut Labs include leading experts in the fields of robotics, neuroscience, and precision medicine. The company has attracted significant investment from prominent venture capital firms focused on healthcare innovation. Key achievements include successful preclinical trials demonstrating the efficacy and safety of Bionauts in navigating and treating deep brain structures. Bionaut Labs' pioneering approach has the potential to significantly impact the field of neurology by offering new therapeutic options for previously intractable CNS conditions.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Medical Devices
Technology
AI, Robotics
Tags
Biotech, Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Enterprise, Healthcare
Customer Type(s)
Global
When was Bionaut Labs founded?
Bionaut Labs was founded in 2016.
Where is Bionaut Labs’s headquarters located?
Bionaut Labs’s headquarters is located in Ra'anana, M, IL.
When was Bionaut Labs’s last funding round?
Bionaut Labs’s most recent funding round was for $43.2M (USD) in November 2022.
How many employees does Bionaut Labs have?
Bionaut Labs has 61 employees as of Feb 4, 2024.
How much has Bionaut Labs raised to-date?
As of July 05, 2023, Bionaut Labs has raised a total of $63.2M (USD) since Nov 28, 2022.
Add Comparison
Total Raised to Date
$63.2M
USD
Last Update Nov 28, 2022
Last Deal Details
$43.2M
USD
Nov 28, 2022
Series B
Total Employees Over Time
61
As of Feb 2024
Bionaut Labs Address
Ra'anana,
Central District
4366411
Israel
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts